2؉ -dependent enzyme that catalyzes the first step of the de novo folate biosynthetic pathway in bacteria and plants, the 7-deazapurine biosynthetic pathway in Bacteria and Archaea, and the biopterin pathway in mammals. We recently reported the discovery of a new prokaryoticspecific GCYH-I (GCYH-IB) that displays no sequence identity to the canonical enzyme and is present in ϳ25% of bacteria, the majority of which lack the canonical GCYH-I (renamed GCYH-IA). Genomic and genetic analyses indicate that in those organisms possessing both enzymes, e.g., Bacillus subtilis, GCYH-IA and -IB are functionally redundant, but differentially expressed. Whereas GCYH-IA is constitutively expressed, GCYH-IB is expressed only under Zn 2؉ -limiting conditions. These observations are consistent with the hypothesis that GCYH-IB functions to allow folate biosynthesis during Zn 2؉ starvation. Here, we present biochemical and structural data showing that bacterial GCYH-IB, like GCYH-IA, belongs to the tunneling-fold (T-fold) superfamily. However, the GCYH-IA and -IB enzymes exhibit significant differences in global structure and activesite architecture. While GCYH-IA is a unimodular, homodecameric, Zn 2؉ -dependent enzyme, GCYH-IB is a bimodular, homotetrameric enzyme activated by a variety of divalent cations. The structure of GCYH-IB and the broad metal dependence exhibited by this enzyme further underscore the mechanistic plasticity that is emerging for the T-fold superfamily. Notably, while humans possess the canonical GCYH-IA enzyme, many clinically important human pathogens possess only the GCYH-IB enzyme, suggesting that this enzyme is a potential new molecular target for antibacterial development.
The Zn 2ϩ -dependent enzyme GTP cyclohydrolase I (GCYH-I; EC 3.5.4.16) is the first enzyme of the de novo tetrahydrofolate (THF) biosynthesis pathway ( Fig. 1) (38) . THF is an essential cofactor in one-carbon transfer reactions in the synthesis of purines, thymidylate, pantothenate, glycine, serine, and methionine in all kingdoms of life (38) , and formylmethionyl-tRNA in bacteria (7) . Recently, it has also been shown that GCYH-I is required for the biosynthesis of the 7-deazaguanosine-modified tRNA nucleosides queuosine and archaeosine produced in Bacteria and Archaea (44) , respectively, as well as the 7-deazaadenosine metabolites produced in some Streptomyces species (33) . GCYH-I is encoded in Escherichia coli by the folE gene (28) and catalyzes the conversion of GTP to 7,8-dihydroneopterin triphosphate (55) , a complex reaction that begins with hydrolytic opening of the purine ring at C-8 of GTP to generate an N-formyl intermediate, followed by deformylation and subsequent rearrangement and cyclization of the ribosyl moiety to generate the pterin ring in THF (Fig. 1) . Notably, the enzyme is dependent on an essential active-site Zn 2ϩ that serves to activate a water molecule for nucleophilic attack at C-8 in the first step of the reaction (2) .
A homologous GCYH-I is found in mammals and other higher eukaryotes, where it catalyzes the first step of the biopterin (BH 4 ) pathway (Fig. 1) , an essential cofactor in the biosynthesis of tyrosine and neurotransmitters, such as serotonin and L-3,4-dihydroxyphenylalanine (3, 52) . Recently, a distinct class of GCYH-I enzymes, GCYH-IB (encoded by the folE2 gene), was discovered in microbes (26% of sequenced Bacteria and most Archaea) (12) , including several clinically important human pathogens, e.g., Neisseria and Staphylococcus species. Notably, GCYH-IB is absent in eukaryotes.
The distribution of folE (gene product renamed GCYH-IA) and folE2 (GCYH-IB) in bacteria is diverse (12) . The majority of organisms possess either a folE (65%; e.g., Escherichia coli) or a folE2 (14%; e.g., Neisseria gonorrhoeae) gene. A significant number (12%; e.g., B. subtilis) possess both genes (a subset of 50 bacterial species is shown in Table 1 ), and 9% lack both genes, although members of the latter group are mainly intracellular or symbiotic bacteria that rely on external sources of folate. The majority of Archaea possess only a folE2 gene, and the encoded GCYH-IB appears to be necessary only for the biosynthesis of the modified tRNA nucleoside archaeosine (44) except in the few halophilic Archaea that are known to synthesize folates, such as Haloferax volcanii, where GCYH-IB is involved in both archaeosine and folate formation (13, 44) .
Expression of the Bacillus subtilis folE2 gene, yciA, is controlled by the Zn 2ϩ -dependent Zur repressor and is upregulated under Zn 2ϩ -limiting conditions (17) . This led us to propose that the GCYH-IB family utilizes a metal other than Zn 2ϩ to allow growth in Zn 2ϩ -limiting environments, a hypothesis strengthened by the observation that an archaeal ortholog from Methanocaldococcus jannaschii has recently been shown to be Fe 2ϩ dependent (22) . To test this hypothesis, we investigated the physiological role of GCYH-IB in B. subtilis, an organism that contains both isozymes, as well as the metal dependence of B. subtilis GCYH-IB in vitro. To gain a structural understanding of the metal dependence of GCYH-IB, we determined high-resolution crystal structures of Zn 2ϩ -and Mn 2ϩ -bound forms of the N. gonorrhoeae ortholog. Notably, although the GCYH-IA and -IB enzymes belong to the tunneling-fold (T-fold) superfamily, there are significant differences in their global and active-site architecture. These studies shed light on the physiological significance of the alternative folate biosynthesis isozymes in bacteria exposed to various metal environments, and offer a structural understanding of the differential metal dependence of GCYH-IA and -IB.
MATERIALS AND METHODS
Enzyme activity assays. All chemicals were of analytical, metal-free grade from Sigma or Fisher. All solutions were prepared with Milli-Q water (18.2 M⍀/cm) and treated with Chelex-100 (Bio-Rad) to remove contaminating metals. Glass and plastic ware were soaked in nitric acid (10%), then in EDTA (5 mM), and rinsed liberally with Chelex-treated Milli-Q water before use. The genes encoding B. subtilis and N. gonorrhoeae GCYH-IB were overexpressed in E. coli and the recombinant proteins purified as previously described (12) . Protein concentrations were determined spectrophotometrically using an extinction coefficient of 25,590 M Ϫ1 calculated according to Gill and von Hippel (19) . Fluorescence-based activity assays were conducted as described previously (12) , using either variable concentrations of metal or EDTA (5 mM), and 0.1 mM GTP. Fluorescence was measured with a SpectraMax Gemini XPS spectrofluorometer (Molecular Devices).
Steady-state kinetic analysis of B. subtilis GCYH-IB was carried out in the presence of 100 mM HEPES (pH 8.0), 100 mM KCl, 0.5 mM MnCl 2 , 1 mM dithiothreitol (DTT), 0.5 M protein, and variable concentrations of GTP (3 to 50 M) under initial velocity conditions. Apoenzyme preparation. Metal ions were removed from B. subtilis and N. gonorrhoeae GCYH-IB by incubating a solution (0.5 ml) of the purified, recombinant protein in 50 mM Tris-HCl (pH 8.0), 50 mM KCl, and 5 mM EDTA for 1 h at room temperature, followed by performing dialysis thrice against a 4-liter solution of 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 5 mM EDTA, and a few grams of Chelex-100. The resulting apoenzyme was dialyzed thrice against 3 liters of 50 mM Tris-HCl (pH 8.0), 50 mM KCl, and Chelex-100 to remove EDTA, then passed through Chelex-100 resin (5 ml protein solution per 3 ml resin) prior to activity assays and metal analysis. Metal content was determined by inductively coupled plasma mass spectrometry (HP-4500 ICP-MS) at the Trace Element Laboratory in the Department of Geology (Portland State University).
Metal activation studies. The B. subtilis apoenzyme (2 M) was incubated with various concentrations (0.1 M to 4 mM) of metal chlorides (MnCl 2 , ZnCl 2 , MgCl 2 , NiCl 2 , CaCl 2 , CdCl 2 , CoCl 2 , CuCl 2 , CoCl 3 , FeCl 3 ) or Fe(SO 4 ) in standard buffer (100 mM HEPES [pH 8.0], 100 mM KCl) for 10 min at 37°C, then assayed for activity as described previously (12) . All assays involving Fe 2ϩ were conducted in an anaerobic chamber with degassed and N 2 -purged buffers.
Reconstitution of B. subtilis GCYH-IB with Mn 2؉ or Zn
2؉
. The apoenzyme was incubated in the presence of 7 molar equivalents of MnCl 2 or ZnCl 2 in standard buffer containing 2 mM DTT for 60 min at 25°C. Loosely bound metal was removed either by dialysis twice against 50 mM Tris-HCl (pH 8.0), 50 mM KCl, and 1 mM DTT for 4 h at 4°C, gel filtration on a Sephadex G-25 column, or by extensive washing with buffer in an Amicon ultra-centrifugal device. The enzyme was assayed for activity as described above, and the metal content was determined by ICP-MS.
Gel filtration chromatography of N. gonorrhoeae GCYH-IB. The native molecular mass of recombinant, wild-type N. gonorrhoeae GCYH-IB (affinity tag removed) was determined by high-performance liquid chromatography (HPLC) on a BioSep-SEC-S4000 gel filtration column (300 mm by 7. Inc.). GCYH-IB and the standard proteins (300 g) were eluted in a buffer of 20 mM sodium phosphate (pH 7.2) and 100 mM NaCl at a flow rate of 1 ml/min, using a Hitachi HPLC system comprised of an L-7100 pump, L-4500A detector, L-7300 column oven, and LaChrome software. ␤-Amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrome c (12.4 kDa) were used as molecular weight (MW) standards, and the void volume was determined from the elution volume of blue dextran. Elution of the proteins from the column was monitored by absorbance at 280 nm.
Crystallization and X-ray data collection. Selenomethionine (SeMet)-labeled enzyme was overproduced in the E. coli methionine auxotroph B834(DE3) (Novagen) following standard methods (24) . The enzyme was purified and the His 6 tag removed as described previously (12) . Selenium substitution was verified with mass spectrometry.
SeMet-labeled GCYH-IB was crystallized at 20°C by vapor diffusion in 2 l sitting drops containing enzyme [9 mg/ml in 50 mM Tris-acetate, 100 mM KCl, ␤-mercaptoethanol (BME; pH 8.0)], polyethylene glycol 6000 (10 to 16%), LiCl (1 to 1.4 M), Tris (50 mM, pH 9.0), and Tris-HCl (50 mM, pH 7.0). The Mn-reconstituted enzyme (10 mg/ml in 50 mM Tris-HCl, 50 mM KCl, 1 mM DTT [pH 8.0]) was crystallized under similar conditions but using metal-free reagents (Chelex-100-pretreated Milli-Q water and ultra-pure reagents from Hampton, Inc.) with 1 to 10 mM MnCl 2 and 12 mM sodium azide (as a preservative) added to the protein solution prior to crystallization.
Crystals were cryo-protected in mother liquor plus ethylene glycol (25%) and flash-cooled in liquid nitrogen. For the SeMet-labeled enzyme, a three-wavelength selenium data set was collected at the Advanced Light Source (ALS, Berkeley, CA) beamline 8.2.2. For the GCYH-IB ⅐ Mn 2ϩ complex, crystals were back-soaked in metal-free reservoir solution for 1 h prior to cryo protection and a single-wavelength data set was collected from a single crystal at Stanford Synchrotron Radiation Laboratory (SSRL, Stanford, CA) beamline 7 to 1. X-ray data were processed in HKL2000 (39) .
Structure determination. The crystal structure of GCYH-IB was determined by the multiwavelength anomalous dispersion method using Se as the anomalous scatterer. An initial heavy-atom substructure of 15 Se sites was identified using the Phenix-HySS program (1). Heavy-atom positions, occupancies, and atomic displacement parameters were refined in SHARP (11) , and initial phases were calculated using all Se sites. Phases were improved by density modification with DM (9) or CCP4 (45) using data in the resolution range 50 to 2.2 Å and 47% solvent content (mean figure of merit increased from 0.34 to 0.85). A 2.2 Å FoFOM map was calculated and auto-traced in ARP/warp software (43) , where 418 of the 514 residues in the asymmetric unit were built. The model was manually completed and partially rebuilt in Coot (14) , utilizing the twofold noncrystallographic symmetry (NCS) relation. Subsequent crystallographic refinement was carried out with Phenix-refine software (1), using NCS restraints and twin lattice symmetry parameterization (3 domains per monomer). (Isotropic B-group constraints were applied to disordered parts of the model.) Finally, fЈ and fЉ were refined in Phenix to final values of Ϫ6.4 and 5.6, Ϫ5.4 and 4.9, and Ϫ5.6 and 3.5, for the peak, inflection and remote wavelength, respectively. Solvent molecules and ions were added, and the structure was further refined in Crystallography and NMR Systems (CNS) (4) after removal of NCS restraints and was validated using Procheck (54) . The electron density for residues 146 to 160 and 188 to 210 of monomer A was weak with refined temperature factors of Ͼ60 Å 2 , indicating that this region is disordered. The crystal structure of the GCYH-IB ⅐ Mn 2ϩ complex was determined by direct difference Fourier calculation in which a protein model based on the crystal structure of the Zn 2ϩ -metallated enzyme was used to calculate phases. The structure was rigid-body-refined in CNS, then refined in refmac (36) from CCP4 while applying NCS restraints and solvent flattening. NCS restraints were removed in a second refmac run. Ligands and solvent molecules were modeled in Coot (version 0.3.3) (14) , and final refinement was completed in refmac.
Bioinformatics. Analysis of the folE/folE2 gene distribution was performed using the SEED annotation environment. Results are made available in the "Folate biosynthesis" subsystem at http://theseed.uchicago.edu/FIG/index.cgi. Candidate Zur binding sites were identified using the Genome Explorer software (41) by scanning bacterial genomes with two position-specific weight matrices constructed using the training sets of two different sets of known Zur binding sites in proteobacteria and firmicutes (42) .
B. subtilis strain construction and growth conditions. All strains were derived from the B. subtilis 168 trpc2 attSP␤ wild-type strain, CU1065, and were grown in a defined minimal medium as previously described (17) or in LB. Growth curves were done using a Bioscreen CMBR system for 24 h with measurements of optical density at 600 nm every 10 min. Liquid overnight cultures with antibiotics were used to start precultures that were diluted at mid-log to a normalized (17) . optical density at 600 nm of 0.01 in a volume of 200 l in a 100-well honeycomb microtiter plate, at which point the growth curve was started. Cultures were incubated at 37°C with shaking at 200 rpm. For selection, antibiotics were added at the following concentrations: 1 g/ml erythromycin and 25 g/ml lincomycin (for selecting for macrolide-lincosamide-streptogramin B resistance), 100 g/ml spectinomycin, and 15 g/ml kanamycin.
folE, folE2, and zur mutants were constructed using long-flanking-homology PCR as previously described (6) . Long-flanking-homology PCR and chromosomal DNA transformation were used to generate strains expressing various combinations of GCYH-I enzymes. Specifically, strain HB6788 (CU1065 folE::mls) lacks GCYH-IA while its GCYH-IB is repressed, but its gene is still present (designated the ⌬folE mutant). This strain was used for construction of other strains. Strain HB6783 (CU1065 folE::mls zur::kan) expresses only GCYH-IB in minimal medium (designated the ⌬folE ⌬zur mutant). Strain HB6852 (CU1065 folE::mls zur::kan folE2::spc) lacks both GCYH-I isozymes (designated the ⌬folE ⌬zur ⌬folE2 mutant).
Protein structure accession numbers. Coordinates and structure factors for GCYH-IB and GCYH-IB ⅐ Mn crystal structures have been deposited into the Protein Data Bank (PDB) under accession numbers 3D1T and 3D2O, respectively.
RESULTS
GCYH-IB functionally replaces GCYH-IA in B. subtilis under zinc-limiting conditions. B. subtilis has both folE and folE2 genes (also known as mtrA and yciA, respectively). To determine whether GCYH-IB can functionally replace GCYH-IA, we constructed a B. subtilis ⌬folE mutant and investigated its complementation with GCYH-IB. In a defined, low-Zn 2ϩ minimal medium (no added Zn 2ϩ ), cells expressing GCYH-IA grew well (Fig. 2) . However, the ⌬folE mutant had a significant lag time and a reduced logarithmic growth rate (Fig. 2 ). This lag is consistent with the repression of GCYH-IB expression by Zur in the beginning of the growth when, even with no added Zn 2ϩ , there is sufficient contaminating Zn 2ϩ to activate Zur. We speculate that the transition to more-rapid growth results from derepression of GCYH-IB when Zn 2ϩ is depleted and Zur repression is released. Indeed, a ⌬folE ⌬zur double mutant, in which GCYH-IB is constitutively expressed, displayed a greatly reduced lag phase (Fig. 2) . However, the constitutive expression of GCYH-IB did not support wild-type levels of growth in this minimal medium, although this strain did grow at the same rate as the wild-type strain in rich (LB) medium (data not shown). As expected, the ⌬folE ⌬zur ⌬folE2 triple mutant strain, expressing neither GCYH-IA nor GCYH-IB, was unable to grow in either minimal (Fig. 2 ) or rich (data not shown) medium. Taken together, these results indicate that GCYH-IB can functionally replace GCYH-IA in B. subtilis under Zn 2ϩ -limiting conditions. Zur-dependent regulation of folE2 is conserved across bacterial species. The expression of GCYH-IB in B. subtilis is controlled by the Zn-dependent Zur repressor and is thus upregulated under Zn-limiting conditions (17) , consistent with a metal ion other than Zn as the physiological metal for this family of cyclohydrolases. To investigate whether orthologs of folE2 in other bacteria are similarly subject to Zur-mediated control, we analyzed bacterial regulons by the use of a comparative genomics approach (18, 48) . Annotation of the folE and folE2 genes in available genomes had been previously performed (3) . Two position-specific weight matrices were constructed for known Zur binding sites from gram-positive and gram-negative bacteria (42) and were used to scan for candidate Zur binding sites in 5Ј untranslated regions of folE2 and neighbor genes in bacterial genomes. To account for possible operon structures, we also analyzed upstream regions of genes that are likely cotranscribed with the folE2 gene (i.e., chains of adjacent genes in the same orientation with intergenic distances not exceeding 100 nucleotides).
Strong Zur operator sites were identified upstream of folE2 genes in 21 bacterial genomes (Table 1 ). This unique regulatory feature is conserved across phyla, including examples in 15 gammaproteobacteria (Pseudomonadales, Xanthomonadales, some enterobacteria, and other lineages), three betaproteobacteria (some Burkholderiales), and three Bacillus species. Notably, all organisms that have the Zur-regulated folE2 gene also contain a copy of folE (e.g., B. subtilis). Similarly, no Zur regulatory sites were found upstream of folE2 genes in those organisms that lack the Zn 2ϩ -dependent GCYH-IA isozyme (e.g., N. gonorrhoeae). These results show that Zur regulation of GCYH-IB is widespread and suggest that in bacteria possessing both folE and folE2, like B. subtilis, the GCYH-IB isozyme is expressed under Zn 2ϩ -limiting conditions to replace the Zn-dependent GCYH-IA.
GCYH-IB and GCYH-IA have different metal requirements in vitro. It is well established that GCYH-IA uses a bound Zn 2ϩ ion for activity (2) . To investigate the metal dependence of GCYH-IB, the purified recombinant B. subtilis enzyme was assayed for activity in the presence of a variety of metal ions or EDTA. While no activity was observed in the presence of EDTA, the presence of several metal ions supported catalysis (data not shown). To obtain unambiguous, quantitative data on the effect of various metal ions on catalytic activity, the enzyme was first demetallated by dialyzing against an EDTA/ FIG. 2. GCYH-IB-dependent complementation of the B. subtilis ⌬folE mutant strain. Growth curves in defined minimal medium for wild-type (WT) and mutant B. subtilis strains expressing either or both types of GCYH-I. Results for the wild-type strain expressing GCYH-IA (}), the ⌬folE2 strain expressing GCYH-IA ({), the ⌬folE strain with delayed expression of GCYH-IB (■), the ⌬folE ⌬zur strain expressing GCYH-IB (OE), and the ⌬folE2 ⌬folE ⌬zur strain with no GCYH-IA or IB expression (F) are shown. [51] and E. coli [2] IA enzymes, respectively).
While Mn 2ϩ is clearly more effective in supporting catalysis, it appears to bind with lower affinity than does Zn 2ϩ (Table 2 and Fig. 3 ). However, as suggested by the absence of enzymatic activity in the presence of EDTA, neither metal appears to bind tightly to the enzyme. Indeed, when the enzyme is analyzed for metal content after purification, only substoichiometric amounts of metal are detected by ICP-MS (metal/protein mole ratios of 0.048 and 0.002 for Zn 2ϩ and Mn 2ϩ , respectively). Furthermore, even when the apoenzyme is remetallated and then subjected to conditions designed to remove loosely bound metals (e.g., gel filtration), again only substoichiometric quantities of metal are detected (metal/protein mole ratios of 0.043 and 0.002 for Zn 2ϩ and Mn 2ϩ , respectively). These results are in marked contrast to those observed for GCYH-IA, in which Zn 2ϩ was observed to bind very tightly to the human enzyme (50) and incubation of the Zn 2ϩ -metallated enzyme with a variety of metal chelators failed to demetallate the enzyme and had no effect on catalytic activity. The results of those studies also showed that the enzyme was catalytically active with metal-free GTP, not metallated GTP. Our data do not allow us to conclude whether the enzyme binds free GTP or metallated GTP, but given the low affinity of metals for GCYH-IB, the enzyme may be active with either, depending on the ambient metal and GTP concentrations.
Native MW of N. gonorrhoeae GCYH-IB. Determination of the native MW of GCYH-IB was done by gel filtration (Fig. 4) after calibration of the column with five standard proteins (Fig.  4, inset) . Gel filtration analysis of recombinant, wild-type N. gonorrhoeae GYCH-IB provided an elution time of 9.2 min (Fig. 4) , corresponding to an apparent MW of 108,559 Ϯ 2,975. Given that the calculated MW of GCYH-IB is 28,568, the data are consistent with a tetramer quaternary structure (3.8 subunits calculated from the data) for the enzyme in the solution.
A tetramer structure is consistent with the structures for the other known bimodular members of the T-fold superfamily (8) .
Crystal structure of GCYH-IB reveals a T-fold. To understand the structural basis of the metal requirement of GCYH-IB, we determined its crystal structure in two forms-one for the recombinant enzyme purified in solutions lacking added metal (GCYH-IB) and one for the apoenzyme remetallated with manganese (GCYH-IB ⅐ Mn). Enzymes from both B. subtilis and N. gonorrhoeae were pursued for crystallization, but only the N. gonorrhoeae ortholog produced diffracting crystals. The two orthologs are 64% similar and 35% identical in sequence and possess similar biochemical properties in vitro (data not shown).
The crystal structure of GCYH-IB was determined by seleno-MAD methods (Fig. 5 and Table 3 ). Two monomers, A and B, were identified in the asymmetric unit. The final structure is missing residues 1 to 13 of monomer A and residues 1 to 14 of monomer B of the total 257 amino acids in each monomer, and contains two Zn 2ϩ ions and one acetate molecule. A homotetrameric complex representing the probable biological state of the enzyme could be generated from the asymmetric-unit dimer by a crystallographic twofold rotation operation (Fig. 5A) . The monomer is a globular subunit com- posed of nine ␤-strands and six ␣-helices (Fig. 6A) , of which eight sequential antiparallel ␤-strands (␤1 to ␤6, ␤8, and ␤9) and four antiparallel ␣-helices (␣1, ␣2, ␣4, and ␣6) form a core with the classic T-fold architecture characteristic of bimodular pterin and purine binding enzymes (8) . In this core, a highly twisted eight-stranded ␤-sheet is layered on its concave side with four antiparallel ␣-helices. The dimer of the asymmetric unit is constructed by a cyclic arrangement of the two eightstranded ␤-sheets from the two monomers to form a 16-stranded antiparallel ␤-barrel. In the biological homotetramer, two ␤-barrels join together head-to-head to form a central tunnel that is 60 Å long and 17 Å in diameter (Fig. 5A) . A search for similar structures was done using the DALI search engine and the FSSP database (fold classification based on structure-structure alignment of proteins) (26) . Several bimodular T-fold enzymes were identified, as well as GCYH-IA ) information in parentheses.
where I(h) i is the ith observation of reflection h and I(h) is the mean intensity of all observations of reflection h.
c R der ϭ ⌺ h ͉F PH Ϫ F P ͉/⌺ h ͉F P ͉, where ͉F P ͉ and ͉F PH ͉ are the observed structure factor amplitudes of the native and the derivative, respectively. d The dispersive differences were treated as isomorphous replacement information where the data collected at a wavelength of 0.9747 Å are treated as native data. e R anom ϭ ⌺ h ͉F PHϩ Ϫ F PHϪ ͉/⌺ h ͉F PH ͉, where ͉F PHϩ ͉ and ͉F PHϪ ͉ are the Friedel pair observed structure factor amplitudes of the derivative at a given wavelength, and F PH is their average.
where ͉F H ͉ is the calculated heavy-atom structure factor for reflection h.
where P() is the probability of a phase value of for reflection h.
where ⌬ obs ANO and ⌬ calc ANO are the Friedel pair differences in the observed and calculated structure factor amplitudes, respectively, for reflection h.
h During density modification, structure factors were calculated for remote-wavelength data in the resolution range 2.3 to 2.2 Å. i Anomalous pairs treated as separate reflections. j Crystallographic R factor ϭ 100 ϫ (⌺ h ͉͉F obs (h)͉ Ϫ ͉F calc (h)͉͉)/⌺ h ͉F obs (h)͉, where F obs (h) and F calc (h) are the observed structure factor amplitude and the structure factor amplitude calculated from the model, respectively. The free R factor was monitored with 10% and 5% of the data excluded from refinement for GCYH-IB and GCYH-IB ⅐ Mn 
Comparison of GCYH-IA and GCYH-IB structures. GCYH-IB is a homotetramer built around a bimodular ␤8␣4
T-fold core ( Fig. 5A and 6A ) while GCYH-IA is a homodecamer ␤4␣2 unimodular T-fold enzyme (Fig. 5C and 6C) . Pairwise structural comparison of the monomeric subunits of GCYH-IB and E. coli GCYH-IA (PDB ID 1FBX) (46) using the DaliLite server (25) yielded an alignment strictly in the four ␤-strands and two ␣-helices (␤2, ␤3, ␤5, ␤6, ␣6, and ␣7 of GCYH-IA, and ␤5, ␤6, ␤8, ␤9, ␣4, and ␣6 of GCYH-IB) of the T-fold (rmsd, 3.2 Å over 94 C ␣ atoms; Fig. 6C ). Based on this (34) . The N-and C-terminal modules of the core bimodular T-fold are shown in magenta and cyan, respectively. C ␣ trace superpositions of the N-terminal (magenta) and C-terminal (cyan) modules of GCYH-IB with corresponding enzymes (green) are shown in panels B and C. Secondary structure nomenclature is shown for the two isozymes.
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GTP CYCLOHYDROLASE IB 6943 alignment, a multisequence alignment of the two enzyme subfamilies in the shared core region was generated (15 sequences of each; Fig. 7 ). The new alignment differs significantly from our previously reported alignment that was based on sequence information and predicted tertiary structure (12) . In the current alignment, the two subfamilies exhibit 28% sequence similarity and only two invariant residues-the metal and substrate liganding residues Cys147 and Glu216 (N. gonorrhoeae numbers), respectively. This unusually low primary structural identity, compared with 7 to 17% sequence identity and 39 to 53% sequence similarity between T-fold enzymes in general, explains the improper annotation of GCYH-IB genes in genomic databases and limited success in previous attempts to generate a model of the tertiary structure by sequence-based homology modeling (12) . In addition to the absence in GCYH-IB of the N-and Cterminal domains found in GCYH-IA (Fig. 6C) , the following functionally important differences are seen in the T-fold domain, specifically in the active site. (i) There is an insertion in GCYH-IB of a two-turn ␣-helix (␣3) between the first two strands (␤5 and ␤6) of the common T-fold ␤-sheet (Fig. 6A and C and 7). This change results in the loss of the Zn 2ϩ binding loop C110EHH113 found in GCYH-IA (E. coli numbering), although the Cys residue is retained (Fig. 7) . (ii) There is an insertion in GCYH-IB of a ␤-strand (␤7) and ␣-helix (␣5) between the two ␣-helices (␣4 and ␣6) of the T-fold (Fig. 6A  and C and 7) . ␤7 and ␣5 are part of the intersubunit interface that harbors the active site. Significantly, ␣5 provides the strictly conserved Glu201 as a carboxylate ligand to the activesite metal ion in GCYH-IB (see below). (iii) There is a deletion in GCYH-IB of helix ␣8 found in the T-fold domain of GCYH-IA (Fig. 6A and C and 7) . Importantly, ␣8 contains the second Cys ligand to Zn 2ϩ in GCYH-IA. This Cys is missing in GCYH-IB, and the helix is replaced with a ␤-turn containing the strictly conserved residues Glu243, His246, and His248.
Rearranged metal binding site and accommodation of Mn 2؉ . As in GCYH-IA, the active site of GCYH-IB is located at the interface between three subunits-two from one ␤-barrel and one from the head-to-head-facing ␤-barrel of the biological multimer. Two of the four active sites in the GCYH-IB homotetramer are partially disordered in the crystal. Each of the four active sites encompasses the metal binding site and the putative GTP binding pocket with the conserved Glu216 that serves to anchor the substrate guanine moiety, a characteristic feature of all T-fold proteins (8) .
The presence of bound Zn 2ϩ in the GCYH-IB crystal was confirmed by an X-ray fluorescence scan near the Zn absorption edge (see the figure in the supplemental material) and by an omit Fo-Fc map (Fig. 8A) . Zn 2ϩ is bound in a trigonal bipyramidal geometry and is coordinated by the thiol group of Cys147, a side chain oxygen atom of Glu201 from the neighboring subunit, and an oxygen atom from a bound acetate molecule (present in the protein sample at 50 mM) as equatorial ligands, and Nε of His159 and a water molecule as the bottom and top axial ligands, respectively ( Fig. 8A and B) . The average Zn 2ϩ -to-ligand distance is 2.4 Å. Although the active site as a whole putatively involves three subunits, the metal binding site involves residues from only two subunits, one from each ␤-barrel.
The liganding side chains, their positions in the Zn 2ϩ coordination sphere, and the protein secondary structure elements in which they lie are different from those seen in GCYH-IA. For illustration, the three-dimensional alignment with the crystal structure of the T. thermophilus enzyme, the highest-resolution available structure of GCYH-IA, is shown in Fig. 8 . In E. coli (PDB ID 1FBX [46] ) and T. thermophilus GCYH-IA (PDB ID 1WM9 [51] ), Zn 2ϩ is coordinated in a distorted incomplete trigonal bipyramidal geometry by two thiol groups and a histidine side chain (Cys110, Cys181, His113 in E. coli residue numbers [Fig. 7] ; Cys108, Cys179, His111 in T. thermophilus residue numbers [ Fig. 8B]) as equatorial ligands all from the same subunit and by a water molecule as an axial ligand. The liganding side chains come from the loop between the first two ␤-strands of the T-fold (␤2 and ␤3 in T. thermophilus GCYH-IA nomenclature in Fig. 7 ) and a short ␣-helix (␣8) (Fig. 7) . These Zn 2ϩ liganding side chains and coordination geometry are preserved in all available structures of zinc-containing GCYH-IA, including the human (2) and rat (31, 32) enzymes. In contrast, in GCYH-IB, the metal binding site is formed by two GCYH-IB-specific insertions: the helix-loop insertion (␣3) between the first two ␤-strands of the T-fold (␤5 and ␤6) and the helical insertion ␣5 from the neighboring subunit. Despite a similar coordination geometry, the average Zn 2ϩ -to-ligand distance in GCYH-IA is 2.32 Å (2, 51, 31, 32), slightly shorter than that in GCYH-IB.
Crystals of GCYH-IB remetallated with Mn 2ϩ (GCYH-IB ⅐ Mn) were grown using Zn 2ϩ -free reagents. The presence of bound Mn 2ϩ was confirmed with an X-ray emission spectrum and fluorescence scan near the Mn 2ϩ absorption edge following a wash and 1-h back soak of the crystal in metal-free solution (see the figure in the supplemental material). The crystal structure was determined by difference Fourier methods using model phases from the Zn 2ϩ -metallated structure ( Table 3 ). The two structures are similar and superpose with an rmsd of 0.3 Å over 486 C ␣ atoms. Metal coordination and distances are also similar, except for the replacement of acetate with azide (added to the acetate-free protein sample at 12 mM concentration prior to crystallization) as an equatorial ligand to Mn 2ϩ (Fig. 8C) . Although the identity of the bound metal cannot be confirmed from the difference Fourier maps, the presence of an absorption edge for Mn 2ϩ after a back soak of the crystal confirms the presence of bound Mn 2ϩ . Putative GTP binding pocket. To elucidate the GTP binding site of GCYH-IB, we are conducting crystallographic analyses of complexes of N. gonorrhoeae GCYH-IB with GTP derivatives 8-oxo-GTP and 7-deaza-GTP. Meanwhile, we generated a docking model of 8-oxo-GTP onto N. gonorrhoeae GCYH-IB based on the superposition of the zinc-containing N. gonorrhoeae GCYH-IB crystal structure with that of the complex of T. thermophilus GCYH-IA with 8-oxo-GTP and zinc (PDB ID 1WUQ [51] ), the only available structure of a ternary complex of GCYH-IA with zinc and a substrate derivative. Notably, the structures of GCYH-IA from a variety of sources (E. coli, T. thermophilus, human, and rat) are virtually identical (e.g., comparison of the crystal structures of human GCYH-IA without bound substrate [PDB ID 1FB1] and T. thermophilus GCYH-IA with 8-oxo-GTP yields an rmsd of 0.9 Å over 182 C ␣ atoms), and the active-site residues are invariant, so the comparison with T. thermophilus GCYH-IA should be relevant for all GCYH-IA members. In the T. thermophilus structure, 8-oxo-GTP, an extremely tight-binding inhibitor, presumably mimics the intermediate that forms immediately following nucleophilic attack at C-8 of GTP in the first step of catalysis (51) . The superposition was applied such that the T-fold core of the N-terminal module of one N. gonorrhoeae GCYH-IB subunit and the T-fold core of the C-terminal module of the adjacent subunit in the same ␤-barrel align maximally with the T-fold cores of two adjacent subunits of the unimodular T. thermophilus GCYH-IA, hence aligning the intersubunit interface that harbors the active site. The superposition was done using the secondary-structure matching (SSM) protocol of Coot (29) and yielded an rmsd of 3.0 Å over 96 C ␣ atoms. Based on this superposition, 8-oxo-GTP was docked manually into the active site of N. gonorrhoeae GCYH-IB and subjected to energy minimization in CNS (4). The docking model indicates that, as in GCYH-IA, the substrate binds near the metal site in the cleft between three subunits, two from one ␤-barrel and one from the opposite ␤-barrel of the GCYH-IB tetramer (Fig. 9) . The following similarities and differences are seen between the two enzyme subfamilies in the substrate binding pocket. (i) The substrate conformation and orientation in the active site of the two enzymes are similar. (ii) In GCYH-IA, the substrate binding cleft is deep and is covered from the front by helix ␣2 from the subunit in the opposite ␤-barrel (T. thermophilus nomenclature in Fig. 9B ). In GCYH-IB, the cleft is shallow and more open and is covered from the top by helix ␣5 from the subunit in the opposite ␤-barrel (N. gonorrhoeae GCYH-IB nomenclature in Fig. 9A ). (iii) One of the two side chains that interact with the guanine base in GCYH-IA is conserved in GCYH-IB (the invariant Glu150 in GCYH-IA; Glu216 in GCYH-IB). The other is His177 in helix ␣8 which is absent in GCYH-IB ( Fig. 7 and 9 ). (iv) Three of the five basic residues (Arg64, His111, and Arg183) that stabilize the substrate triphosphate moiety in GCYH-IA come from secondary structure elements that are absent in GCYH-IB, namely helix ␣2, the ␤2-␤3 loop, and helix ␣8, respectively, of GCYH-IA ( Fig. 7 and 9 ). The other two basic side chains (Lys134 and Arg137) are not conserved and can be either acidic or neutral in GCYH-IB (Fig.  7) . Instead, in GCYH-IB, the triphosphate appears to be stabilized by a patch of conserved basic residues from the adjacent subunit (His59 and Arg62) and the subunit in the opposite ␤-barrel (Lys197 and Arg198) (Fig. 9A) . (v) The only activesite residue that interacts via its side chain with the substrate ribose moiety in GCYH-IA is Ser133, which is positionally conserved in GCYH-IB and comes from the adjacent subunit (Ser61) (Fig. 9A) , although it is too distant to interact with the ribose moiety in the present model. Additionally, the side chains of the GCYH-IB-specific active-site residues Glu243, His246, and His248 are within 5 Å from the ribose moiety in the docking model, indicating that they may participate in catalysis.
In conclusion, the docking model suggests that the GTP binding interactions in GCYH-IB are significantly different from those in GCYH-IA, despite similar orientations of the substrate in the active site.
DISCUSSION

Zn
2ϩ is an essential cofactor for numerous proteins. In bacteria and eukaryotes, cellular Zn 2ϩ levels are sensed by specific transcription factors such as the repressor Zur in B. subtilis and E. coli (23, 35) and the activator Zap1p in Saccharomyces cerevisiae (30) . Cellular responses to low Zn 2ϩ conditions include increased expression of high-affinity Zn 2ϩ transporters, such as ZnuABC, and substitution of Zn 2ϩ -dependent proteins/enzymes with alternative proteins/isozymes that do not rely on this metal ion as a cofactor. Examples of the latter strategy include Zn 2ϩ -dependent regulation of the alcohol dehydrogenase isozyme ADH4 in yeast (30) and paralogs of ribosomal protein S14 in B. subtilis (37) .
Results from the present study clearly show that in B. subtilis, folE encodes the housekeeping Zn 2ϩ -dependent GCYH-IA used under normal growth conditions, when Zn 2ϩ is readily available. In contrast, folE2, encoding the newly discovered GCYH-IB, is derepressed when Zn 2ϩ is low, thereby allowing folate biosynthesis even under Zn 2ϩ -limiting conditions. This observation can be generalized to most organisms that contain copies of both the folE and folE2 genes, since in these organisms expression of folE2 is controlled by an upstream Zur repressor site. On the other hand, organisms that do not possess the Zn 2ϩ -dependent GCYH-IA isozyme (e.g., N. gonorrhoeae) consistently lack a Zur regulatory site upstream of the folE2 gene and rely solely on constitutively expressed GCYH-IB for folate biosynthesis (12) .
The identification of the "correct" in vivo metal ion for a protein is often problematic when different metal ions support the relevant biological activity in vitro. [20] ). In contrast, free Zn 2ϩ levels are estimated to be at most 1 pM (S. Gabriel and J. D. Helmann, unpublished observations), consistent with previous measurements in E. coli (40) . Thus, despite the apparent tighter binding observed for Zn 2ϩ , it is highly unlikely that Zn 2ϩ is involved to any significant extent in GCYH-IB activity in vivo. Indeed, absolute affinity is not necessarily the relevant measure for identification of the in vivo metal; from the Irving-Williams series (16, 27) (20) , yet functions physiologically as a manganese-specific sensor since zinc levels in the cell are far below those required for metallation of MntR. MncA, which binds Zn 2ϩ with an affinity of ϳ10 5 greater than that for Mn 2ϩ (53) , is observed to bind (22) , respectively. Interestingly, in the latter case the product is also different, as the archaeal GCYH-IB has been shown to produce dihydroneopterin cyclic phosphate (22) , not dihydroneopterin triphosphate as observed with GCYH-IA (5) and bacterial GCYH-IB (12) . Sequence conservation of key metal binding residues indicates that a metal dependence distinct from that of GCYH-IA is a property of the GCYH-IB enzyme family in general. For example, the introduction of an acidic side chain (Glu201) in the metal site of GCYH-IB allows accommodation of Mn 2ϩ , which exhibits a greater preference for oxygen ligands than for Zn 2ϩ . The identification of the physiologically relevant cofactor for bacterial GCYH-IB enzymes will require further study and, given the ability of the B. subtilis enzyme to be activated by several metal ions, may vary between organisms or in response to changing metal ion availability. In the specific case of N. gonorrhoeae, we note that this organism survives in the highly oxidizing environment created by the host immune response and accumulates millimolar levels of Mn 2ϩ , an effective scavenger of reactive oxygen species (ROS) (49) . A similar utilization of Mn 2ϩ to fight ROS damage resulting from radiation exposure occurs in Deinococcus radiodurans (10) , which also contains only GCYH-IB. In these organisms, Mn 2ϩ is likely to be the physiologically relevant metal for GCYH-IB activation.
Structural analysis clearly demonstrates that GCYH-IB, like GCYH-IA, is a member of the T-fold family, but unlike the IA enzyme, GCYH-IB is a member of the bimodular subfamily, not the unimodular subfamily. The T-fold structural superfamily is comprised of functionally distant enzymes assembled through a common oligomerization of the T-fold, a protein fold comprised of a pair of two-stranded antiparallel ␤-sheets and two helices, to form a ␤ 2n ␣ n barrel (8) . In the functional enzymes, two barrels associate in a head-to-head fashion and similarly, bind planar substrates of purine/pterin structures at the interface of monomers and use a conserved Glu/Gln to anchor the substrate. Although the crystallographic asymmetric unit of GCYH-IB is a dimer forming a single barrel, the crystal structure reveals that a substantial 32% of the total monomeric surface is buried in the homotetramer (26.4% of the monomer surface area is buried in the intradimer interface and 22.3% of the dimer surface area is buried in the interdimer interface), consistent with a stable tetrameric structure. The gel filtration data demonstrate that the tetramer is the stable form of the enzyme in solution, and given that the crystal structure reveals that the active site is comprised of residues from three subunits, with the key metal binding residues originating from subunits in different barrels, it is unlikely that the dimer is the biological form of the enzyme. A similar structural organization is observed in DHNA, and in this case, the architecture leads to posttranslational regulation by metal-induced oligomerization (21) . It is not clear whether metal binding induces oligomerization and formation of the GCYH-IB tetramer. In the crystal structure of the N. europaea GCYH-IB ortholog (PDB ID 2R5R [Midwest Center for Structural Genomics, unpublished data]), no bound metal is found (possibly due to use of chelating agents during protein purification) despite the conserved metal binding site. Yet, the structure reveals a homotetrameric quaternary arrangement identical to that of N. gonorrhoeae GCYH-IB, indicating that metal binding is not necessary for the formation of the biological tetramer. Taken together, these observations indicate that the probable biological form of the enzyme is the tetramer, similar to urate oxidase (47), the T-fold family member showing the highest structural similarity to GCYH-IB.
As demonstrated for GCYH-IA (51), the metal ion in GCYH-IB likely serves to activate a bound water molecule for nucleophilic attack in the first step of the reaction, and to stabilize the formyl intermediate generated after the opening of the purine ring. However, the differences in the putative GTP binding pocket and associated metal dependence between GCYH-IA and -IB suggest that differences in catalytic strategies for the two enzyme families may exist and further underscores the remarkable mechanistic plasticity of the T-fold superfamily. Indeed, this superfamily supports an extraordinarily diverse range of chemistries while exhibiting virtually identical tertiary structures for the core T-fold domain (8) . Notably, the significant differences in the active-site architecture of the GCYH-IA and -IB enzymes, coupled with the occurrence of the latter enzyme in a number of clinically important human pathogens that lack GCYH-IA (Table 1) and thus depend solely on GCYH-IB for folate biosynthesis, position GCYH-IB as a potential new molecular target for the development of antibacterial agents against growing threats such as methicillin (meticillin)-resistant Staphylococcus aureus. Portions of this research were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences.
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